| 15494-8 |
Pasteurella multocida Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Pasteurella multocida Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
Titer group 3 |
|
|
|
|
|
MICRO |
|
15494-8 |
|
IA |
|
|
Both |
|
|
|
0 |
P multoc Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian pasterurellosis; EIA; ELFA; ELISA; Enzyme immunoassay; Fowl cholera; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; P multoc; P multocida; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 15495-5 |
Porcine reproductive and respiratory syndrome virus Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
PRRSV Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg; 0.423 |
|
|
|
|
|
MICRO |
|
15495-5 |
|
IA |
|
|
Both |
|
|
|
0 |
PRRSV Ab Ser Ql IA |
|
|
|
|
|
Abortus blauw; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue-eared pig disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Lelystad virus; MEIA; Microbiology; Mystery swine disease; Ordinal; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PR; PRRS; PRRSV; PRRSV Ab; Ql; Qual; Qualitative; Random; Screen; Serum; Seuchenhafter spatabort der schweine; SIRSV; SR; SUDS; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.; Abbreviated "Porcine reproductive and respiratory syndrome virus" to "PRRSV" in the Long Common Name. PRRSV is shorter and more commonly used in test names. |
0 |
| 15496-3 |
Porcine reproductive and respiratory syndrome virus Ab |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
PRRSV Ab [Presence] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15496-3 |
|
IF |
|
|
Both |
|
|
|
0 |
PRRSV Ab Ser Ql IF |
|
|
|
|
|
Abortus blauw; ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Blue-eared pig disease; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Lelystad virus; Microbiology; Mystery swine disease; Ordinal; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PR; PRRS; PRRSV; PRRSV Ab; Ql; Qual; Qualitative; Random; Screen; Serum; Seuchenhafter spatabort der schweine; SIRSV; SR; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Time Resolved Fluorescence; TRF; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Abbreviated "Porcine reproductive and respiratory syndrome virus" to "PRRSV" in the Long Common Name. PRRSV is shorter and more commonly used in test names.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15497-1 |
Pseudorabies virus Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Pseudorabies virus Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15497-1 |
|
IA |
|
|
Both |
|
|
|
0 |
PRV Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Alpha-herpesvirus; Antby; Anti; Antibodies; Antibody; Aujeszky's disease; Aujeszkys Disease Virus; Aujezskys disease; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; PHV1; Point in time; Porcine herpes virus 1; PR; PRV; Pseudorabies; QL; Qual; Qualitative; Random; Screen; Serum; SHV-1; SR; SUDS; Suid herpesvirus-1; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15498-9 |
Pseudorabies virus Ab |
PrThr |
Ser |
Pt |
Ord |
LA |
|
ACTIVE |
Pseudorabies virus Ab [Presence] in Serum by Latex agglutination |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15498-9 |
|
LA |
|
|
Both |
|
|
|
0 |
PRV Ab Ser Ql LA |
|
|
|
|
|
ABS; Aby; Alpha-herpesvirus; Antby; Anti; Antibodies; Antibody; Aujeszky's disease; Aujeszkys Disease Virus; Aujezskys disease; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; LAT; Latex agglutination; Microbiology; Ordinal; PHV1; Point in time; Porcine herpes virus 1; PR; PRV; Pseudorabies; QL; Qual; Qualitative; Random; Screen; Serum; SHV-1; SR; Suid herpesvirus-1; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15499-7 |
Pseudorabies virus Ab.Neut |
Titr |
Ser |
Pt |
SemiQn |
Neut |
|
ACTIVE |
Pseudorabies virus neutralizing antibody [Titer] in Serum by Neutralization test |
|
MAJ |
DefinitionDescription |
|
|
titer |
Neg@1:4 |
|
|
|
|
|
MICRO |
|
15499-7 |
|
Neut |
|
|
Both |
|
|
|
0 |
PRV NAb Titr Ser Nt |
|
|
|
Y |
|
ABS; Aby; Alpha-herpesvirus; Antby; Anti; Antibodies; Antibody; Aujeszky's disease; Aujeszkys Disease Virus; Aujezskys disease; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; PHV1; Point in time; Porcine herpes virus 1; PRV; Pseudorabies; Random; Serum; Serum virus neutralization; SHV-1; SmQn; SR; Suid herpesvirus-1; SVN; Titer; Titered; Titre; Ttr; Vet; Veterinary; Virus neutralization test; VNT |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.; |
0 |
| 155-2 |
Cephaloglycin |
Titr |
Isolate+Ser |
Pt |
SemiQn |
SBT |
|
ACTIVE |
Cephaloglycin [Susceptibility] by Serum bactericidal titer |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
ABXBACT |
|
155-2 |
|
SBT |
|
|
Observation |
|
|
|
0 |
Cephaloglycin Titr SBT |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 1550-3 |
Glucose^pre 12H CFst |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1550-3 |
|
|
|
|
Both |
|
|
|
0 |
Glucose pre 12h fast SerPl-mCnc |
|
|
|
Y |
|
Before; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Fast; Fasting; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; PC; Pl; Plasma; Plsm; Point in time; pre 12h fast; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 15500-2 |
Pseudorabies virus.ClinEase gene deletion Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15500-2 |
|
IA |
|
|
Both |
|
|
|
0 |
PRV Clinease Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Alpha-herpesvirus; Antby; Anti; Antibodies; Antibody; Aujeszky's disease; Aujeszkys Disease Virus; Aujezskys disease; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; PHV1; Point in time; Porcine herpes virus 1; PR; PRV; PRV Clinease; Pseudorabies; QL; Qual; Qualitative; Random; Screen; Serum; SHV-1; SR; SUDS; Suid herpesvirus-1; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15501-0 |
Pseudorabies virus.HerdCheck gene deletion Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15501-0 |
|
IA |
|
|
Both |
|
|
|
0 |
PRV Herdcheck Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Alpha-herpesvirus; Antby; Anti; Antibodies; Antibody; Aujeszky's disease; Aujeszkys Disease Virus; Aujezskys disease; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; PHV1; Point in time; Porcine herpes virus 1; PR; PRV; PRV Herdcheck; Pseudorabies; QL; Qual; Qualitative; Random; Screen; Serum; SHV-1; SR; SUDS; Suid herpesvirus-1; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15502-8 |
Pseudorabies virus.OmniMark gene deletion Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15502-8 |
|
IA |
|
|
Both |
|
|
|
0 |
PRV Omnimark Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Alpha-herpesvirus; Antby; Anti; Antibodies; Antibody; Aujeszky's disease; Aujeszkys Disease Virus; Aujezskys disease; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; PHV1; Point in time; Porcine herpes virus 1; PR; PRV; PRV Omnimark; Pseudorabies; QL; Qual; Qualitative; Random; Screen; Serum; SHV-1; SR; SUDS; Suid herpesvirus-1; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15503-6 |
Pseudorabies virus.Tolvid gene deletion Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15503-6 |
|
IA |
|
|
Both |
|
|
|
0 |
PRV Tolvid Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Alpha-herpesvirus; Antby; Anti; Antibodies; Antibody; Aujeszky's disease; Aujeszkys Disease Virus; Aujezskys disease; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; PHV1; Point in time; Porcine herpes virus 1; PR; PRV; PRV Tolvid; Pseudorabies; QL; Qual; Qualitative; Random; Screen; Serum; SHV-1; SR; SUDS; Suid herpesvirus-1; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15504-4 |
Salmonella arizonae Ab |
PrThr |
Ser |
Pt |
Ord |
Aggl |
|
ACTIVE |
Salmonella arizonae Ab [Presence] in Serum by Agglutination |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15504-4 |
|
Aggl |
|
|
Both |
|
|
|
0 |
S arizonae Ab Ser Ql Aggl |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Paracolon; Point in time; PR; QL; Qual; Qualitative; Random; S arizonae; Sal; Salmonel; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15505-1 |
Salmonella pullorum Ab |
PrThr |
Ser |
Pt |
Ord |
Aggl |
|
ACTIVE |
Salmonella pullorum Ab [Presence] in Serum by Agglutination |
|
MIN |
DefinitionDescription |
|
|
|
Pos; Neg |
|
|
|
|
|
MICRO |
|
15505-1 |
|
Aggl |
|
|
Both |
|
|
|
0 |
S pullorum Ab Ser Ql Aggl |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Pullorum disease; QL; Qual; Qualitative; Random; S pullorum; Sal; Salmonel; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Updated Answer list type from NORMATIVE to EXAMPLE because the Answers in the list (Positive, Negative) are only examples of possible answers and not an exclusive list |
0 |
| 15506-9 |
Salmonella typhimurium Ab |
PrThr |
Ser |
Pt |
Ord |
Aggl |
|
ACTIVE |
Salmonella typhimurium Ab [Presence] in Serum by Agglutination |
|
MIN |
DefinitionDescription |
|
|
|
Neg@1:8 |
|
|
|
|
|
MICRO |
|
15506-9 |
|
Aggl |
|
|
Both |
|
|
|
0 |
S Typhimur Ab Ser Ql Aggl |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S Typhimur; S typhimurium; Sal; Salmonel; Screen; Serum; SR; Vet; Veterinary |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 15507-7 |
Progress note |
Find |
Emergency department |
Pt |
Doc |
{Role} |
|
ACTIVE |
Emergency department Progress note |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
15507-7 |
|
{Role} |
|
|
Both |
|
|
|
0 |
ED Prog note |
|
|
|
|
|
DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Based on Clinical LOINC Committee approval on 8/16/2011, the Component was changed from Subsequent evaluation note to Progress note. The term "Subsequent evaluation" seems to be used infrequently and is more commonly referred to as a Progress note. Also changed class from ATTACH.CLINRPT to DOC.CLINRPT since this term is conformant to the Document Ontology axis values and therefore being placed in this class.; Based on Clinical LOINC Committee decision during the September 2014 meeting, {Provider} was changed to {Author Type} to emphasize a greater breadth of potential document authors. At the September 2015 Clinical LOINC Committee meeting, the Committee decided to change {Author Type} to {Role} to align with the 'Role' axis name in the LOINC Document Ontology. |
0 |
| 15508-5 |
Labor and delivery records |
Find |
^Patient |
- |
Doc |
|
|
ACTIVE |
Labor and delivery records |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
15508-5 |
|
|
|
|
Both |
|
|
|
0 |
Labor and delivery records |
|
|
|
|
|
DOC.MISC; Document; Finding; Findings; MISC |
2.67 |
1.0k |
Y |
|
|
|
|
|
|
|
|
|
|
0 |
| 15509-3 |
Rationale for scheduled transport |
Type |
Ambulance transport |
Pt |
Nom |
|
|
ACTIVE |
Ambulance transport, Rationale for scheduled transport |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.AMB |
|
15509-3 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.AMB; Nominal; Point in time; Random; Typ |
2.27 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 1551-1 |
Glucose^pre 50 g lactose PO |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --pre 50 g lactose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1551-1 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose pre 50 g Lac PO SerPl-mCnc |
|
|
|
Y |
|
Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; Mass concentration; Pl; Plasma; Plsm; Point in time; pre 50 g Lac PO; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 15510-1 |
Distance transported |
Len |
Ambulance transport |
Pt |
Qn |
|
|
ACTIVE |
Ambulance transport, Distance transported Length |
|
MIN |
DefinitionDescription |
|
|
mi;km |
|
|
|
|
|
|
ATTACH.AMB |
|
15510-1 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
Y |
|
ATTACH; ATTACH.AMB; Length; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
1.0k |
|
|
|
|
|
|
|
[mi_us];km |
|
|
|
0 |
| 15511-9 |
Origination site information |
Cmplx |
Ambulance transport |
Pt |
Set |
|
|
ACTIVE |
Ambulance transport, Origination site information Set |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.AMB |
|
15511-9 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.AMB; Complex; Point in time; Random |
2.4 |
1.0l |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 15512-7 |
Destination site information |
Cmplx |
Ambulance transport |
Pt |
Set |
|
|
ACTIVE |
Ambulance transport, Destination site information Set |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.AMB |
|
15512-7 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.AMB; Complex; Point in time; Random |
2.4 |
1.0l |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 15513-5 |
Reason for scheduled trip |
Cmplx |
Ambulance transport |
Pt |
Set |
|
|
ACTIVE |
Ambulance transport, Reason for scheduled trip Set |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.AMB |
|
15513-5 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.AMB; Complex; Point in time; Random |
2.4 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 15514-3 |
Ordering practitioner ID |
Type |
Ambulance transport |
Pt |
Nom |
|
|
ACTIVE |
Ambulance transport, Ordering practitioner identifier type |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.AMB |
|
15514-3 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.AMB; Identifier; Intradermal; Nominal; Ordering pract ID; Point in time; Random; Typ |
2.38 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 15515-0 |
Medical reason for transport |
Imp |
Ambulance transport |
Pt |
Nom |
|
|
ACTIVE |
Ambulance transport, Medical reason for transport |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.AMB |
|
15515-0 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.AMB; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random |
2.27 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
